Moreover, combining an inhibitor of the phosphoinositide 3-kinase (PI3K) pathway or of cyclin-dependent kinase-4/6 (CDK4/6) with AZD9496 led to an enhanced tumour inhibitory effect8. The gene discussed is CDK4; the disease is neoplasm.